首页> 外国专利> IgG2a antibody fraction from body fluid of HIV patients - obtd. during latent phase of infection, deep frozen and re-administered, used for AIDS treatment

IgG2a antibody fraction from body fluid of HIV patients - obtd. during latent phase of infection, deep frozen and re-administered, used for AIDS treatment

机译:来自HIV患者体液的IgG2a抗体馏分-obtd。在潜在的感染阶段,深层冷冻并重新使用,用于艾滋病治疗

摘要

An antibody fraction (A) obtd. from the body fluids of HIV infected patients in the latent phase of infection, is new. (A) pref. contains IgG2a type antibodies and is isolated from blood, cerebrospinal fluid, semen, sputum or tissue fluids of patients. USE/ADVANTAGE - (A) is used for treatment of AIDS or for preventing progression of infection. Partic. it is admin. during the latent phase and will then maintain the patient in that phase. (A) can be returned to the subject from whom it was derived, i.e., an autoimmune passive transfer which reduces the risk of inducing allergic reactions.
机译:抗体级分(A)。从艾滋病毒感染者的体液中处于潜在的感染阶段,是新的。 (一)首选含有IgG2a型抗体,并从患者的血液,脑脊液,精液,痰或组织液中分离出来。使用/优势-(A)用于治疗艾滋病或预防感染的进展。参加这是管理员。在潜伏期,然后将患者保持在该阶段。 (A)可以返回至其来源,即自身免疫被动转移,其降低了诱发过敏反应的风险。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号